Income Statement
VAXCYTE, INC.
PCVX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
923.68 | 569.55 | 468.04 | 232.26 | 103.67 | 89.58 |
|
Research & Development
|
794.31 | 476.64 | 332.34 | 169.45 | 78.41 | 73.56 |
|
Selling, General & Administrative
|
129.37 | 92.90 | 60.70 | 39.81 | 25.26 | 16.02 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-923.68 | -569.55 | -468.04 | -232.26 | -103.67 | -89.58 |
|
Non-Operating Income
|
157.05 | - | - | - | - | - |
|
Interest Income
|
119.72 | 109.99 | 62.91 | 8.36 | 0.34 | 0.24 |
|
Interest Expense
|
- | - | 0.00 | 0.00 | 0.01 | 0.01 |
|
Other Non-Op Income / Expense
|
37.33 | 105.62 | 65.78 | 8.77 | 3.59 | 0.36 |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-766.63 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-907.28 | -562.54 | -464.89 | -229.68 | -101.87 | -88.18 |
|
Earnings Per Share (Basic)
|
-5.63 | -3.80 | -4.14 | -3.44 | - | - |
|
Diluted EPS
|
-5.63 | -3.80 | -4.14 | -3.44 | - | - |
|
Weighted Average Shares
|
136.09 | 122.00 | 97.16 | 64.88 | - | - |
|
Diluted Weighted Avg Shares
|
136.09 | 122.00 | 97.16 | 64.88 | - | - |
|
Comprehensive Income
|
-761.17 | -467.98 | -401.73 | -223.61 | -100.32 | - |